COVID-19 vaccine works well during treatment of solid tumors


Most patients with tumors in an organ or tissue who are receiving treatment with immunotherapy and/or chemotherapy respond well to the COVID-19 vaccine. A study conducted by MC Groningen, Erasmus MC in Rotterdam, and the Netherlands Cancer Institute in Amsterdam, in collaboration with the RIVM and the Netherlands Comprehensive Cancer Organization (IKNL), shows that it is safe and usually effective to vaccinate these patients. The results of this study were presented on September 20 at the European Society of Medical Oncology congress and will be published in the medical journal The Lancet Oncology.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.